Palliative interventions for controlling vaginal bleeding in advanced cervical cancer

Area of Science:

• Gynecologic Oncology
• Palliative Care
• Evidence-Based Medicine

Background:

• Cervical cancer is a leading cause of death in women globally, with advanced stages frequently presenting with severe vaginal bleeding.
• Vaginal bleeding in advanced cervical cancer is a distressing symptom that can be life-threatening and challenging to manage.
• Current evidence lacks systematic reviews on palliative interventions for controlling this symptom.

Purpose of the Study:

• To systematically evaluate the efficacy and safety of interventions like tranexamic acid, vaginal packing, and interventional radiology compared to radiotherapy for palliative treatment of vaginal bleeding in advanced cervical cancer.

Main Methods:

• A comprehensive search of multiple databases (CENTRAL, Cochrane, MEDLINE, EMBASE) and clinical trial registers was conducted.
• Included studies were randomized and non-randomized comparative studies evaluating specific interventions against radiotherapy.
• Two independent reviewers assessed study eligibility; however, no studies met the inclusion criteria.

Main Results:

• The search identified 1335 unique references, with 22 full articles retrieved, but none met the inclusion criteria for controlled trials.
• Only observational, single-arm data were found for interventions such as formalin-soaked packs, interventional radiology, and radiotherapy.
• No comparative data were available to assess the efficacy or safety of the evaluated interventions.

Conclusions:

• There is a lack of evidence from controlled trials to support or refute the use of interventions like tranexamic acid or vaginal packing compared to radiotherapy for managing vaginal bleeding in advanced cervical cancer.
• Treatment choices currently depend on local resource availability, as radiotherapy is often inaccessible in resource-poor settings where advanced cervical cancer is prevalent.
• A randomized controlled trial is urgently needed to assess the benefits and risks of palliative treatments for vaginal bleeding in women with advanced cervical cancer.